Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 1;3(5):e206369.
doi: 10.1001/jamanetworkopen.2020.6369.

Missed Opportunities to Save Lives-Treatments for Opioid Use Disorder After Overdose

Elizabeth M Schoenfeld  1 , Lauren M Westafer  1 , William E Soares 3rd  1
Affiliations
Comment

Missed Opportunities to Save Lives-Treatments for Opioid Use Disorder After Overdose

Elizabeth M Schoenfeld et al. JAMA Netw Open. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

No Conflicts of Interest.

Figures

Figure
Figure
Known barriers to implementation, as mapped to CFIR domains.
See this image and copyright information in PMC

Comment on

References

    1. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction. Lancet. 1988. August 13;2(8607):349–60. And https://www.thennt.com/nnt/aspirin-for-major-heart-attack/ (Accessed February 20, 2020) - PubMed
    1. Weiner SG, Baker O, Bernson D, Schuur JD. One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose. Annals of Emergency Medicine. June 2019. doi: 10.1016/j.annemergmed.2019.04.020. - DOI - PMC - PubMed
    1. Larochelle MR, Bernson D, Land T, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality. Ann Intern Med. 2018;169(3):137–18. doi: 10.7326/M17-3107. - DOI - PMC - PubMed
    1. Kilaru AS, Xiong A, Lowenstein M, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852. doi: 10.1001/jamanetworkopen.2020.5852 - DOI - PMC - PubMed
    1. Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities. Health Affairs. 2019;38(1):14–23. doi: 10.1377/hlthaff.2018.05162. - DOI - PMC - PubMed